Skip to content

Clinical trials

Atrial Fibrillation trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Country / region: Serbia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20141
20151
20161
20172
20181
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advanz Pharma2
Daiichi Sankyo2
ARCA Biopharma, Inc.1
Acesion Pharma1
Anthos Therapeutics, Inc.1
Boehringer Ingelheim1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
HUYABIO International, LLC.1
Heart Care Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation16
Stroke5
Heart Failure4
Hypertension2
Peripheral Arterial Disease2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Flutter1
Cardiovascular Diseases1
Coronary Artery Disease1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.